Literature DB >> 135763

Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex.

G Markus, J L Evers, G H Hobika.   

Abstract

When human plasminogen and the bacterial protein streptokinase are mixed, a tight equimolar complex is formed in which an active center of well defined hydrolytic activity developes; this event precedes the cleavage of the plasminogen chain, i.e. the conversion to plasmin. Immediately after the formation of the complex, a series of proteolytic transformations occurs which, within a few minutes, results in at least two cleavages in the plasminogen, and at least five cleavages in the streptokinase peptide chains. None of the fragments so created seem to dissociate from the main body of the complex, but the activator activity, when measured by a rapid bovine clot-lysis system, undergoes a characteristic pattern of fluctuation coincident with the fragmentation of the two components. When the latter process is followed by sodium dodecyl sulfate gel electrophoresis, the state of fragmentation of the activator can be correlated with the measured activator activities. By manipulating the temperature, and by the introduction of inhibitors, it was possible to slow down, or temporarily arrest, the fragmentation at certain stages, allowing the identification in a number of cases of the predominant activator species, and the determination of a characteristic relative activator activity for it. By the use of such relative activities, it was possible to carry out a calculation, based on electrophoretic analysis alone, which predicted reasonably successfully the kinetics of activator fluctuation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 135763

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator.

Authors:  G L Reed; A K Houng; L Liu; B Parhami-Seren; L H Matsueda; S Wang; L Hedstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  The human plasma fibrinolytic system: regulation and control.

Authors:  K C Robbins
Journal:  Mol Cell Biochem       Date:  1978-08-16       Impact factor: 3.396

Review 3.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

4.  The domain organization of streptokinase: nuclear magnetic resonance, circular dichroism, and functional characterization of proteolytic fragments.

Authors:  J Parrado; F Conejero-Lara; R A Smith; J M Marshall; C P Ponting; C M Dobson
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

5.  Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.

Authors:  P K Anonick; W H Vetter; S L Gonias
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

6.  The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.

Authors:  R Cassels; R Fears; R A Smith
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

7.  Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.

Authors:  R Fears; M J Hibbs; R A Smith
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.